Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 16.86
+0.10 (0.60%)
Jul 31, 2026, 3:00 PM CST
SHA:601607 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 31,212 | 32,722 | 35,744 | 30,518 | 27,401 | 22,390 |
Trading Asset Securities | 9,904 | 10,361 | 8,633 | 10,152 | 9,614 | - |
Cash & Short-Term Investments | 41,117 | 43,083 | 44,377 | 40,670 | 37,015 | 22,390 |
Cash Growth | -8.69% | -2.92% | 9.12% | 9.87% | 65.32% | 0.16% |
Accounts Receivable | 93,857 | 85,866 | 82,217 | 77,163 | 70,187 | 61,006 |
Other Receivables | 2,972 | 2,285 | 2,237 | 2,373 | 1,957 | 1,786 |
Receivables | 96,829 | 88,150 | 84,454 | 79,536 | 72,144 | 62,791 |
Inventory | 41,682 | 45,359 | 38,944 | 36,623 | 34,460 | 27,104 |
Other Current Assets | 3,214 | 3,872 | 4,048 | 5,605 | 5,894 | 4,209 |
Total Current Assets | 182,841 | 180,464 | 171,823 | 162,434 | 149,513 | 116,494 |
Property, Plant & Equipment | 19,244 | 19,286 | 19,175 | 18,006 | 16,550 | 15,793 |
Long-Term Investments | 8,611 | 8,588 | 9,835 | 10,603 | 11,477 | 10,836 |
Goodwill | 12,667 | 12,666 | 11,146 | 11,393 | 11,336 | 11,239 |
Other Intangible Assets | 8,633 | 8,744 | 5,617 | 6,051 | 6,263 | 6,049 |
Long-Term Deferred Tax Assets | 1,692 | 1,640 | 1,628 | 1,717 | 1,535 | 1,368 |
Long-Term Deferred Charges | 102.87 | 103.24 | 215.32 | 785.22 | 342.61 | 259.23 |
Other Long-Term Assets | 1,579 | 1,658 | 1,770 | 983.3 | 1,119 | 1,397 |
Total Assets | 235,369 | 233,149 | 221,209 | 211,973 | 198,135 | 163,436 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 62,356 | 61,405 | 59,483 | 54,632 | 51,566 | 41,995 |
Accrued Expenses | 1,472 | 12,080 | 10,637 | 10,638 | 9,574 | 7,985 |
Short-Term Debt | 51,946 | 49,128 | 44,096 | 41,612 | 33,811 | 31,592 |
Current Portion of Long-Term Debt | 2,169 | 2,125 | 191.8 | 2,366 | 2,649 | 33.44 |
Current Portion of Leases | - | 585.37 | 649.07 | 596.67 | 580.68 | 545.04 |
Current Income Taxes Payable | 1,325 | 875.12 | 835.87 | 809.8 | 781.36 | 721.16 |
Current Unearned Revenue | 1,161 | 1,504 | 1,562 | 1,971 | 2,243 | 1,311 |
Other Current Liabilities | 16,080 | 7,496 | 8,583 | 9,747 | 9,487 | 7,642 |
Total Current Liabilities | 136,509 | 135,198 | 126,038 | 122,372 | 110,691 | 91,824 |
Long-Term Debt | 3,257 | 4,236 | 8,331 | 5,786 | 6,260 | 7,158 |
Long-Term Leases | 1,463 | 1,149 | 1,396 | 1,550 | 1,302 | 1,434 |
Long-Term Unearned Revenue | 551.5 | 573.38 | 550.99 | 633.48 | 534.58 | 2,349 |
Pension & Post-Retirement Benefits | 45.28 | 43.68 | 39.16 | 38.88 | 38.91 | 39.01 |
Long-Term Deferred Tax Liabilities | 1,828 | 1,945 | 816.45 | 1,016 | 1,049 | 998.77 |
Other Long-Term Liabilities | 248.92 | 215.98 | 294.44 | 250.14 | 257.26 | 566.09 |
Total Liabilities | 143,902 | 143,361 | 137,467 | 131,646 | 120,132 | 104,369 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3,708 | 3,708 | 3,708 | 3,703 | 3,698 | 2,842 |
Additional Paid-In Capital | - | 29,645 | 29,588 | 29,188 | 29,098 | 16,071 |
Retained Earnings | 44,447 | 43,029 | 38,854 | 36,129 | 34,639 | 30,591 |
Comprehensive Income & Other | 29,146 | -491.27 | -474.23 | -496.09 | -371.32 | -144.39 |
Total Common Equity | 77,301 | 75,891 | 71,676 | 68,524 | 67,063 | 49,359 |
Minority Interest | 14,166 | 13,896 | 12,067 | 11,802 | 10,939 | 9,707 |
Shareholders' Equity | 91,468 | 89,787 | 83,742 | 80,326 | 78,002 | 59,066 |
Total Liabilities & Equity | 235,369 | 233,149 | 221,209 | 211,973 | 198,135 | 163,436 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 58,835 | 57,224 | 54,664 | 51,911 | 44,602 | 40,762 |
Net Cash (Debt) | -17,718 | -14,141 | -10,287 | -11,241 | -7,587 | -18,372 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.78 | -3.81 | -2.78 | -3.04 | -2.18 | -6.46 |
Filing Date Shares Outstanding | 3,708 | 3,708 | 3,708 | 3,703 | 3,698 | 2,842 |
Total Common Shares Outstanding | 3,708 | 3,708 | 3,708 | 3,703 | 3,698 | 2,842 |
Working Capital | 46,333 | 45,266 | 45,785 | 40,062 | 38,822 | 24,670 |
Book Value Per Share | 20.85 | 20.46 | 19.33 | 18.50 | 18.14 | 17.37 |
Tangible Book Value | 56,002 | 54,482 | 54,913 | 51,080 | 49,464 | 32,071 |
Tangible Book Value Per Share | 15.10 | 14.69 | 14.81 | 13.79 | 13.38 | 11.28 |
Buildings | - | 14,466 | 13,455 | 10,959 | 10,941 | 9,698 |
Machinery | - | 11,943 | 11,302 | 9,982 | 9,054 | 8,203 |
Construction In Progress | - | 1,994 | 2,149 | 3,570 | 2,777 | 2,914 |